- Filed
- May 9, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 6, 2024 | 84.27M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 84.17M sh |
| Shares Diluted restated | Q1 2024 · Apr 2, 2023 | 83.21M sh |
| Capex | Q1 2024 · Mar 31, 2024 | $37.22M |
| Capex | Q1 2024 · Apr 2, 2023 | $25.49M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$30.47M |
| Operating Cash Flow | Q1 2024 · Apr 2, 2023 | −$56.27M |
| Long Term Debt | Q1 2024 · Mar 31, 2024 | $2.13B |
| Long Term Debt | Q1 2024 · Dec 31, 2023 | $2.13B |
| Long Term Debt | Q1 2024 · Apr 2, 2023 | $2.28B |
| Short Term Debt | Q1 2024 · Mar 31, 2024 | $230M |
| Short Term Debt | Q1 2024 · Dec 31, 2023 | $180M |
| Short Term Debt | Q1 2024 · Apr 2, 2023 | $170M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $60.7M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $77.59M |
| Cash And Equivalents | Q1 2024 · Apr 2, 2023 | $64.75M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | −$978.36M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | −$897.96M |
| Stockholders Equity | Q1 2024 · Apr 2, 2023 | −$1.02B |
| Stockholders Equity | Q1 2024 · Jan 1, 2023 | −$950.57M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $705.55M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $587.53M |
| Current Liabilities | Q1 2024 · Apr 2, 2023 | $513.66M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $3.2B |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $3.09B |
| Total Liabilities | Q1 2024 · Apr 2, 2023 | $3.15B |
| Current Assets | Q1 2024 · Mar 31, 2024 | $255.69M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $252.77M |
| Current Assets | Q1 2024 · Apr 2, 2023 | $234.87M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $2.74B |
| Total Assets | Q1 2024 · Dec 31, 2023 | $2.71B |
| Total Assets | Q1 2024 · Apr 2, 2023 | $2.66B |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$0.98 |
| Eps Diluted | Q1 2024 · Apr 2, 2023 | −$0.84 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$0.98 |
| Eps Basic | Q1 2024 · Apr 2, 2023 | −$0.84 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $42.52M |
| Sga Expense | Q1 2024 · Apr 2, 2023 | $44.25M |
| Net Income | Q1 2024 · Mar 31, 2024 | −$82.73M |
| Net Income | Q1 2024 · Apr 2, 2023 | −$69.86M |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$65.2M |
| Operating Income | Q1 2024 · Apr 2, 2023 | −$52.24M |
| Revenue | Q1 2024 · Mar 31, 2024 | $133.29M |
| Revenue | Q1 2024 · Apr 2, 2023 | $142.19M |